10-K/A

FORM 10-K AMENDMENT

Company: Xenetic Biosciences, Inc.
Filed: April 28, 2021
Period of Report: December 31, 2020
Accession Number: 0001683168-21-001582

View Document ↗ View on SEC.gov ↗